While COVID-19–related thyroid inflammation usually resolves shortly after the acute illness, about half of participants in a study presented today at the 24th European Congress of Endocrinology still had thyroid abnormalities a year later. The congress is being held May 21 to 24 in Milan, Italy.
A systematic review and meta-analysis of clinical trials of antibiotic treatment for children with community-acquired pneumonia provides further support for shorter treatment duration, Finnish researchers reported yesterday in Clinical Infectious Diseases.
A related study shows how responding quickly to food illness outbreaks saves lives and significant money.
An increase in resistance to ciprofloxacin among poultry isolates was primarily due to Salmonella Infantis.
The World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), the World Organization for Animal Health (OIE), and the United Nations Environment Programme (UNEP) yesterday published a strategic framework for One Health collaborations on antimicrobial resistance (AMR).
An analysis of antibiotic use for upper respiratory infections (URIs) in Ghana reveals the considerable economic impact of inappropriate prescribing can have on low-resource settings, researchers reported last week in Antimicrobial Resistance & Infection Control.
Venatorx Pharmaceuticals of Malvern, Pennsylvania, yesterday released promising data from a phase 3 trial of its investigational new drug for patients with complicated urinary tract infections (cUTIs).
Fewer than half of US states requiring COVID-19 vaccination or routine testing of schoolteachers included childcare professionals in their mandates, leaving some young children vulnerable to infection by unvaccinated caregivers, according to a study yesterday in JAMA Pediatrics.
The risk of hospitalization, intensive care unit (ICU) admission, and death was much lower among more than 9,000 Canadian COVID-19 patients infected with the Omicron variant than among matched Delta patients, according to a study published yesterday in JAMA.
The risk of hospitalization or death with Omicron was 41% of—and the risk of death was one-tenth of—that of Delta.
The severity of COVID-19 does not change based on pregnancy trimester, finds research presented today at the Society for Maternal-Fetal Medicine's (SMFM's) virtual annual meeting.
